Alfasigma

Drive the global Medical Affairs strategy and execute the medical action plan for linerixibat in gastroenterology and rare diseases. Lead scientific communication, data generation, and medical review while collaborating with commercial and R&D teams.

Define and execute the global strategy for the Gastroenterology and Hepatology therapeutic area, overseeing the clinical pipeline and portfolio investments. Lead the development of clinical programs from early stage through registration while collaborating with cross-functional R&D and commercial teams.